Clearance of blood stream infections in patients receiving extracorporeal membrane oxygenation: a retrospective single-center cohort study

[11] Grasselli G(2021)Epidemiology and clinical characteristics of bloodstream infection in patients under extracorporeal membranous oxygenation Ann Thorac Surg 112 1168-1175

[12] Alagna L(2020)A Retrospective study of infection in patients requiring extracorporeal membrane oxygenation support Lancet Respir Med 8 1121-1131

[13] Steiner CK(2022)Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study J Thorac Cardiovasc Surg 163 2107-2116

[14] Stewart DL(2022)Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: a retrospective multicenter study Infect Control Hosp Epidemiol 43 26-31

[15] Bond SJ(2020)Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts Lancet 396 1071-1078

[16] Hornung CA(2020)Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry Ann Intensive Care 10 158-772

[17] McKay VJ(2021)Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study Infect Control Hosp Epidemiol 42 770-833

[18] Liu C(1999)Elevated secondary infection rates in patients with coronavirus disease 2019 (COVID-19) requiring extracorporeal membrane oxygenation Clin Infect Dis 28 828-166

[19] Bayer A(2001)Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation Infect Control Hosp Epidemiol 22 165-28

[20] Cosgrove SE(1991)Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients Artif Organs 15 23-912

[11] Grasselli G(2021)Epidemiology and clinical characteristics of bloodstream infection in patients under extracorporeal membranous oxygenation Ann Thorac Surg 112 1168-1175

[12] Alagna L(2020)A Retrospective study of infection in patients requiring extracorporeal membrane oxygenation support Lancet Respir Med 8 1121-1131

[13] Steiner CK(2022)Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study J Thorac Cardiovasc Surg 163 2107-2116

[14] Stewart DL(2022)Characteristics and outcomes of patients with COVID-19 supported by extracorporeal membrane oxygenation: a retrospective multicenter study Infect Control Hosp Epidemiol 43 26-31

[15] Bond SJ(2020)Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts Lancet 396 1071-1078

[16] Hornung CA(2020)Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry Ann Intensive Care 10 158-772

[17] McKay VJ(2021)Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study Infect Control Hosp Epidemiol 42 770-833

[18] Liu C(1999)Elevated secondary infection rates in patients with coronavirus disease 2019 (COVID-19) requiring extracorporeal membrane oxygenation Clin Infect Dis 28 828-166

[19] Bayer A(2001)Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation Infect Control Hosp Epidemiol 22 165-28

[20] Cosgrove SE(1991)Blood products: a significant risk factor for long-term catheter-related bloodstream infections in cancer patients Artif Organs 15 23-912